European Antibiotic Awareness Day 2019: Launch event
The launch event is marking the 12th European Antibiotic Awareness Day. It will be hosted by ECDC and the Representation of the European Commission in Sweden and will include keynote speeches, a panel debate, and a public debate with stakeholders and citizens.
ECDC Director to visit Israel
On 4-5 September 2019, ECDC Director will go on a country visit to Israel. The ECDC Director will meet the Director General of the Ministry of Health and senior officials from the Public Health Services, International Relations, Israel Center for Disease Control, Health Emergency Operation Center, Institute for Antibiotic Resistance and Infection Control, and from the Center for Infection Control.
ECDC and the Israel Center for Disease Control (ICDC) signed an administrative agreement in June 2012. The objective of this agreement is to enhance the technical cooperation in the fields of prevention and control of communicable diseases, capacity building and support to preparedness and outbreak response. Additional potential activities include ICDC participation in Disease Programme network meetings, sharing of epidemic intelligence data in the framework of EPISOUTH, participation in simulation exercises and exchange of trainees and experts.
Global Vaccination Summit
The European Commission organises, in cooperation with the World Health Organisation, a Global Vaccination Summit on 12 September 2019, in Brussels.
ECDC holds the annual Observership programme for ESCMID, EUCIC and ESCV members
As every year, ECDC organises a week-long programme for observers from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the European Committee on Infection Control (EUCIC) and the European Society for Clinical Virology (ESCV) from 2 to 6 September 2019. Twenty-one participants are expected to join from all three societies for this annual Observership programme.
Ebola treatment trial: two drugs identified as more effective
Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.
Staying healthy during Pride season: practice safer sex and check vaccination status
Dutch health authorities have recently reported an increase of hepatitis A infections particularly affecting men who have sex with men. With the on-going Pride events across Europe, ECDC stresses the importance of ensuring hepatitis A vaccination, (advice for) safer sex and personal hygiene practices including washing hands and genital areas before and after sex to avoid infection.
Travellers who recently received rabies post-exposure prophylaxis in Philippines advised to contact health services
The recommendation from ECDC follows reports of falsified rabies vaccines and anti-rabies serum circulating in the Philippines and is aimed at travellers who have received the vaccine or serum after possible exposure to rabies.
Targeted testing for viral hepatitis: Europe’s persistent public health challenge
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.